CDLX (Cardlytics) ROE % Adjusted to Book Value: 0.00% (As of Mar. 2026)

Cardlytics CDLX -5.14% 37 ROE % Adjusted to Book Value is 0.00% as of Mar. 2026. GuruFocus rates CDLX with a GF Score™ of 37/100 and a GF Value™ of $18.68 (Possible Value Trap). The stock has 4 warning signs investors should review.

Cardlytics's ROE % for the quarter that ended in Mar. 2026 was 0.00%. Cardlytics's PB Ratio for the quarter that ended in Mar. 2026 was N/A. Cardlytics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was N/A.

Cardlytics ROE % Adjusted to Book Value Related Terms

Cardlytics ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Cardlytics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardlytics ROE % Adjusted to Book Value Chart

Cardlytics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-9.45

-113.33

-28.70

-67.97

0.00

Cardlytics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-53.55	-40.86	0.00	0.00	0.00

CDLX vs SWAG, WIMI, HAFG: ROE % Adjusted to Book Value Comparison

For the Advertising Agencies subindustry, Cardlytics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cardlytics ROE % Adjusted to Book Value vs Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, Cardlytics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cardlytics's ROE % Adjusted to Book Value falls into.

Save Embed

37GF Score

Cardlytics Inc CDLX

ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cardlytics ROE % Adjusted to Book Value Calculation

Cardlytics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-326.02%	/	N/A
	=	N/A

Cardlytics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Frequently Asked Questions Learn more about ROE % Adjusted to Book Value →

What does a ROE % Adjusted to Book Value of 0.00% mean?

Cardlytics (CDLX) has a ROE % Adjusted to Book Value of 0.00% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Cardlytics and its competitors.

Is Cardlytics' ROE % Adjusted to Book Value too high?

Cardlytics' current ROE % Adjusted to Book Value is 0.00%. Overall, Cardlytics has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Cardlytics' ROE % Adjusted to Book Value compare to SWAG and WIMI?

Cardlytics' ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROE % Adjusted to Book Value for a Media - Diversified company?

A good ROE % Adjusted to Book Value depends on the Media - Diversified industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROE % Adjusted to Book Value mean?

A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Cardlytics and its competitors. Cardlytics's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cardlytics stock overvalued right now?

Based on GuruFocus' analysis, Cardlytics (CDLX) is currently considered Possible Value Trap. The stock's GF Value™ is $18.68, compared to a current price of $4.73 — trading 74.7% below its estimated fair value. The current ROE % Adjusted to Book Value is 0.00%. Cardlytics' overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROE % Adjusted to Book Value calculated?

ROE % Adjusted to Book Value is calculated from a company's financial statements. For Cardlytics (CDLX), the current ROE % Adjusted to Book Value is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cardlytics (CDLX) Overvalued in 2026?

Based on GuruFocus' analysis, Cardlytics stock appears to be undervalued. The current stock price of $4.73 is trading 74.7% below its estimated GF Value™ of $18.68. GuruFocus considers Cardlytics to be Possible Value Trap.

Key valuation signals for CDLX:

ROE % Adjusted to Book Value: 0.00%
GF Value™: $18.68 vs. price of $4.73 (74.7% below fair value)
GF Score™: 37/100 with 4 warning signs

No single metric tells the full story. See the CDLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cardlytics Business Description

Industry Communication Services Media - Diversified

Comparable Companies SWAG WIMI HAFG ACCS TULP FLNT MOBQ DLPN STFS TJGC APP XPAR:PUB OMC SZSE:002027 TTD SZSE:300058 SZSE:002131 TSE:4324 XPAR:DEC TSE:4751

Other Exchanges 0LEC:UK CYX0:Germany

Address 675 Ponce de Leon Avenue, NE, Suite 4100, Atlanta, GA, USA, 30308

Website https://www.cardlytics.com

Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.

37GF Score

Get the complete analysis for CDLX

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.73

Price

$18.68

GF Value

View CDLX Analysis

See ROE % Adjusted to Book Value data for all stocks →